Key result
In patients with acute lymphoid leukemia receiving anthracycline chemotherapy, left ventricular ejection fraction values measured by ERNV and 2D-TTE were similar after two cycles of treatment.
Why the study?
Early diagnosis of chemotherapy-induced cardiotoxicity in ALL patients can prevent heart failure, but the correlation between ERNV and more widely available 2D-TTE parameters required evaluation.
Does 2D-TTE correlate with ERNV for early evaluation of LVEF after anthracycline treatment in patients with acute lymphoid leukemia?
Observational (n=44)
No
Does 2D-TTE correlate with ERNV for early evaluation of LVEF after anthracycline treatment in patients with acute lymphoid leukemia?
Answers are grounded in this paper and cite their sources.
In young adults with ALL, LVEF measurements by 2D-TTE and ERNV were correlated before anthracycline therapy, supporting the utility of 2D-TTE for early cardiotoxicity screening.
Introduction: Early diagnosis of cardiac toxicity caused by chemotherapy drugs in acute lymphoid leukemia (ALL) patients can prevent the occurrence of heart failure. Equilibrium radionuclide ventriculography (ERNV) has the advantage of a precise evaluation, while two-dimensional transthoracic echocardiography (2D-TTE) is more widely available. This study aimed to evaluate the correlation of the relevant cardiac toxicity parameters for patients diagnosed with ALL using both of these techniques. Material and methods: Between January 2022 and May 2024, patients with ALL were prospectively evaluated in the hematology department of Imam Khomeini Hospital in Tehran. 2D-TTE and ERNV were performed before and after two cycles of HYPER-CVAD chemotherapy. Patients with cardiac disease, cardiovascular risk or previous anticancer treatment were excluded. Results: Forty-four patients with ALL were included: 24 (54.5%) males and 20 (45.5%) females. The majority of patients (56.8%) were between 20 and 40 years old and had no history of cardiac disease or malignancies. Baseline left ventricular ejection fraction (LVEF) volumes were correlated on 2D-TTE and ERNV (r=0.5; P=0.001). Eleven patients were evaluated after therapy. LVEF values were similar (54.9±8.1 vs. 54.3±4.6; P=0.552) but without a linear correlation (r= 0.3; p=0.409). Only two cardiac parameters were significantly changed after chemotherapy: the pulmonary artery pressure (PAP) on 2D-TTE (24.3±5.5 vs 22.2±5.2; p=0.02) and the time peak filling rate (TTPFR) on ERNV (138.3±39.8 vs 170±52.9 milliseconds; p=0.004). Conclusion: Cardiac function impairment parameters on ERNV and 2D-TTE were similar before and after a cumulative dose of daunorubicin of 100 mg/m2. Before therapy, there was also a linear correlation between values. PAP decreased and TTPFR increased after chemotherapy. Keywords
No takes yet. Share an insight, caveat, or question.
Mohsen et al. (2024) conducted an observational in Acute Lymphoid Leukemia (n=44). Equilibrium Radionuclide Ventriculography (ERNV) vs. Two-Dimensional Transthoracic Echocardiography (2D-TTE) was evaluated on Left ventricular ejection fraction (LVEF) after two cycles of chemotherapy (p=0.552). In patients with acute lymphoid leukemia receiving anthracycline chemotherapy, left ventricular ejection fraction values measured by ERNV and 2D-TTE were similar after two cycles of treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: